Squarepoint’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$298K Buy
2024
Q4
Sell
2024
Q3
$298K Buy
2023
Q2
Sell
2023
Q1
$113K Buy
2021
Q3
Sell
2021
Q2
$214K Sell
2021
Q1
$610K Buy
2020
Q3
Sell
2020
Q2
$180K Sell
2020
Q1
$581K Sell
2019
Q4
$2.19M Sell
2019
Q3
$1.44M Buy
2019
Q2
$1.58M Buy